longbridge

Faeth Therapeutics

FTH
----

All Shareholders

Shareholder Type

  • Institutions41.97%
  • Public and others29.67%
  • Hedge funds13.41%
  • VC/PE firms10.19%
  • Others4.77%

Major Shareholders

Major Shareholders Latest
Shareholder
Khosla Ventures, LLC
10.19%2.63M--+2.63M
Montanova Capital, LLC
7.82%2.02M5.24%+1.99M
Avoro Capital Advisors LLC
5.59%1.44M--+1.44M
Baker Bros. Advisors LP
4.98%1.29M--+1.29M
Balyasny Asset Management L.P.
4.03%1.04M2.82%+1.03M
Cormorant Asset Management, LP
3.98%1.03M18.87%+722.02K
Anand ParikhCEO, President & Chair
3.16%817.70K3.16%+817.70K
Logos Global Management, L.P.
2.79%722.02K0.56%+692.02K
RA Capital Management, L.P.
2.79%722.02K--+722.02K
Vivo Capital, LLC
2.79%722.02K51.07%+0
Fairmount Funds Management LLC
2.79%722.02K--+722.02K
Caligan Partners, LP
2.44%629.47K6.96%+503.47K
The B Group, Inc.
2.36%610.17K--+610.17K
Trails Edge Capital Partners, LP
1.99%515.34K7.33%+390.34K
Franklin Templeton Inc.
1.91%494.52K8.05%+361.01K
Octagon Capital Advisors LP
1.40%361.01K--+361.01K
ADAR1 Capital Management, LLC
1.40%361.01K--+361.01K
H&S Ventures LLC
0.86%222.08K15.71%+0
Marshall Wace LLP
0.80%206.51K4.10%+140.78K
Boxer Capital Management, LLC
0.70%180.51K--+180.51K
© 2026 Longbridge｜Terms of ServicePrivacy Policy